Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rebeca Pelosof, Leonardo A. dos Santos, Luis C. Farhat, Wagner F. Gattaz, Leda Talib & André R. Brunoni. (2023) BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis. The World Journal of Biological Psychiatry 24:1, pages 24-33.
Read now
Read now
Wenhuan Xiao, Qiongqiong Zhan, Fei Ye, Xiaowei Tang, Jin Li, Hui Dong, Weiwei Sha & Xiaobin Zhang. (2019) Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects. The World Journal of Biological Psychiatry 20:2, pages 150-158.
Read now
Read now
Wolnei Caumo, Luciana C Antunes, Jéssica Lorenzzi Elkfury, Evelyn G Herbstrith, Raquel Busanello Sipmann, Andressa Souza, Iraci LS Torres, Vinicius Souza dos Santos & Randy Neblett. (2017) The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor. Journal of Pain Research 10, pages 2109-2122.
Read now
Read now
André R. Brunoni, Chris Baeken, Rodrigo Machado-Vieira, Wagner F. Gattaz & Marie-Anne Vanderhasselt. (2015) BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: A systematic review and meta-analysis. The World Journal of Biological Psychiatry 16:2, pages 114-122.
Read now
Read now
Articles from other publishers (81)
Zhi-De Deng, Pei L. Robins, William Regenold, Paul Rohde, Moritz Dannhauer & Sarah H. Lisanby. (2023) How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?. Neuropsychopharmacology 49:1, pages 150-162.
Crossref
Crossref
Qinghua Guo, Yong Wang, Libo Guo, Xueqi Li, Xiangyun Ma, Xiaoxiao He, Jitao Li, Xiao Zhang & Shaomei Shang. (2023) Long-Term Cognitive Effects of Electroconvulsive Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis. Psychiatry Research, pages 115611.
Crossref
Crossref
Ann-Kathrin Domke, Moritz Hempel, Corinna Hartling, Anna Stippl, Luisa Carstens, Rebecca Gruzman, Ana Lucia Herrera Melendez, Malek Bajbouj, Matti Gärtner & Simone Grimm. (2023) Functional connectivity changes between amygdala and prefrontal cortex after ECT are associated with improvement in distinct depressive symptoms. European Archives of Psychiatry and Clinical Neuroscience 273:7, pages 1489-1499.
Crossref
Crossref
Anna Maria Szota, Beata Kowalewska, Małgorzata Ćwiklińska-Jurkowska & Wiktor Dróżdż. (2023) The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia—A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 12:17, pages 5728.
Crossref
Crossref
Nather Madjid, Veronica Lidell, Gunnar Nordvall, Maria Lindskog, Sven-Ove Ögren, Pontus Forsell & Johan Sandin. (2023) Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?. Psychopharmacology 240:8, pages 1789-1804.
Crossref
Crossref
Helena Bellini, Eric Cretaz, Adriana Munhoz Carneiro, Pedro Henrique Rodrigues da Silva, Leonardo Afonso dos Santos, José Gallucci-Neto & André Russowsky Brunoni. (2023) Magnetic Waves vs. Electric Shocks: A Non-Inferiority Study of Magnetic Seizure Therapy and Electroconvulsive Therapy in Treatment-Resistant Depression. Biomedicines 11:8, pages 2150.
Crossref
Crossref
Zuxing Wang, Zhili Zou, Jun Xiao, Wenjiao Min, Li-Ping Nan, Cui Yuan, Lu Yuan, Chenghui Yang, Rui Huang & Ying He. (2023) Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis. General Hospital Psychiatry 83, pages 86-92.
Crossref
Crossref
Aleksandra Gliwińska, Justyna Czubilińska-Łada, Gniewko Więckiewicz, Elżbieta Świętochowska, Andrzej Badeński, Marta Dworak & Maria Szczepańska. (2023) The Role of Brain-Derived Neurotrophic Factor (BDNF) in Diagnosis and Treatment of Epilepsy, Depression, Schizophrenia, Anorexia Nervosa and Alzheimer’s Disease as Highly Drug-Resistant Diseases: A Narrative Review. Brain Sciences 13:2, pages 163.
Crossref
Crossref
Ming H. Hsieh. 2023.
Shayam Suseelan & Graziano Pinna. 2023.
1
67
.
Haipeng Cai, Ruonan Du, Kebing Yang, Wei Li & Zhiren Wang. (2022) Association between electroconvulsive therapy and depressive disorder from 2012 to 2021: Bibliometric analysis and global trends. Frontiers in Human Neuroscience 16.
Crossref
Crossref
Krzysztof Gbyl, Ulrich Lindberg, Henrik Bo Wiberg Larsson, Egill Rostrup & Poul Videbech. (2022) Cerebral perfusion is related to antidepressant effect and cognitive side effects of Electroconvulsive Therapy. Brain Stimulation 15:6, pages 1486-1494.
Crossref
Crossref
Geert Schurgers, Sharon Walter, Ehsan Pishva, Sinan Guloksuz, Odette Peerbooms, Laura Rodriguez Incio, Baer M.G. Arts, Gunter Kenis & Bart P.F. Rutten. (2022) Longitudinal alterations in mRNA expression of the BDNF neurotrophin signaling cascade in blood correlate with changes in depression scores in patients undergoing electroconvulsive therapy. European Neuropsychopharmacology 63, pages 60-70.
Crossref
Crossref
Tien-Wei Hsu, Che-Sheng Chu, Pao-Yuan Ching, Guan-Wei Chen & Chih-Chuan Pan. (2022) The efficacy and tolerability of memantine for depressive symptoms in major mental diseases: A systematic review and updated meta-analysis of double-blind randomized controlled trials. Journal of Affective Disorders 306, pages 182-189.
Crossref
Crossref
Subha Subramanian, Ruthzaine Lopez, Charles F. Zorumski & Pilar Cristancho. (2022) Electroconvulsive therapy in treatment resistant depression. Journal of the Neurological Sciences 434, pages 120095.
Crossref
Crossref
Marion Psomiades, Marine Mondino, Filipe Galvão, Nathalie Mandairon, Mikail Nourredine, Marie-Françoise Suaud-Chagny & Jérôme Brunelin. (2022) Serum Mature BDNF Level Is Associated with Remission Following ECT in Treatment-Resistant Depression. Brain Sciences 12:2, pages 126.
Crossref
Crossref
Anees Bahji. (2022) The Rise, Fall, and Resurgence of Electroconvulsive Therapy. Journal of Psychiatric Practice 28:6, pages 440-444.
Crossref
Crossref
Riccardo Di Iorio, Simone Rossi & Paolo M. Rossini. (2022) One century of healing currents into the brain from the scalp: From electroconvulsive therapy to repetitive transcranial magnetic stimulation for neuropsychiatric disorders. Clinical Neurophysiology 133, pages 145-151.
Crossref
Crossref
Mark S. George, Kevin A. Caulfield & Melanie Wiley. 2022. Neuroplasticity - From Bench to Bedside. Neuroplasticity - From Bench to Bedside
497
507
.
Hideyuki Iwanaga, Takefumi Ueno, Naoya Oribe, Manabu Hashimoto, Jun Nishimura, Naho Nakayama, Nami Haraguchi, Hiroshi Tateishi, Yutaka Kunitake, Yoshito Mizoguchi & Akira Monji. (2021) Correlation between Post-Acute Electroconvulsive Therapy Alpha-Band Spectrum Power Increase and Improvement of Psychiatric Symptoms. Journal of Personalized Medicine 11:12, pages 1315.
Crossref
Crossref
Dore Loef, Kristof Vansteelandt, Mardien L. Oudega, Philip van Eijndhoven, Angela Carlier, Eric van Exel, Didi Rhebergen, Pascal Sienaert, Mathieu Vandenbulcke, Filip Bouckaert & Annemiek Dols. (2021) The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression. Brain, Behavior, & Immunity - Health 18, pages 100389.
Crossref
Crossref
Tarapati Rana, Tapan Behl, Aayush Sehgal, Pranay Srivastava & Simona Bungau. (2020) Unfolding the Role of BDNF as a Biomarker for Treatment of Depression. Journal of Molecular Neuroscience 71:10, pages 2008-2021.
Crossref
Crossref
Wing-Shan Yu, So-Hyun Kwon, Stephen Kugbere Agadagba, Leanne-Lai-Hang Chan, Kah-Hui Wong & Lee-Wei Lim. (2021) Neuroprotective Effects and Therapeutic Potential of Transcorneal Electrical Stimulation for Depression. Cells 10:9, pages 2492.
Crossref
Crossref
Bruno Perosa Carniel & Neusa Sica da Rocha. (2021) Brain-derived neurotrophic factor (BDNF) and inflammatory markers: Perspectives for the management of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 108, pages 110151.
Crossref
Crossref
Mark David Tricklebank, Trevor W. Robbins, Camilla Simmons & Erik H. F. Wong. (2021) Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology. Psychopharmacology 238:6, pages 1417-1436.
Crossref
Crossref
Krzysztof Gbyl, Mette Marie Støttrup, Jayachandra Mitta Raghava, Song Xue Jie & Poul Videbech. (2021) Hippocampal volume and memory impairment after electroconvulsive therapy in patients with depression. Acta Psychiatrica Scandinavica 143:3, pages 238-252.
Crossref
Crossref
Stephan Goerigk, Eric Cretaz, Bernardo Sampaio-Junior, Érica Leandro Marciano Vieira, Wagner Gattaz, Izio Klein, Beny Lafer, Antônio Lúcio Teixeira, André F. Carvalho, Paulo A. Lotufo, Isabela M. Benseñor, Markus Bühner, Frank Padberg & André R. Brunoni. (2021) Effects of tDCS on neuroplasticity and inflammatory biomarkers in bipolar depression: Results from a sham-controlled study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 105, pages 110119.
Crossref
Crossref
Mi Jin Park, Hyewon Kim, Eun Ji Kim, Vidal Yook, In Won Chung, Sang Min Lee & Hong Jin Jeon. (2021) Recent Updates on Electro-Convulsive Therapy in Patients with Depression. Psychiatry Investigation 18:1, pages 1-10.
Crossref
Crossref
Meysam Amidfar, Gislaine Zilli Réus, Airam Barbosa de Moura, João Quevedo & Yong-Ku Kim. 2021. Major Depressive Disorder. Major Depressive Disorder
257
272
.
Adriano H. Moffa, André R. Brunoni & Colleen K. Loo. 2021. Transcranial Direct Current Stimulation in Neuropsychiatric Disorders. Transcranial Direct Current Stimulation in Neuropsychiatric Disorders
465
480
.
Aleksander Nobis, Daniel Zalewski & Napoleon Waszkiewicz. (2020) Peripheral Markers of Depression. Journal of Clinical Medicine 9:12, pages 3793.
Crossref
Crossref
Juliette Giacobbe, Carmine M Pariante & Alessandra Borsini. (2020) The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies. Journal of Psychopharmacology 34:10, pages 1086-1097.
Crossref
Crossref
Sonani Mindt, Michael Neumaier, Rainer Hellweg, Alexander Sartorius & Laura Kranaster. (2020) Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression. The Journal of ECT 36:3, pages 193-197.
Crossref
Crossref
Alexandra S. Troyan & Oleg A. Levada. (2020) The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy. Frontiers in Psychiatry 11.
Crossref
Crossref
Lucas Borrione, Helena Bellini, Lais Boralli Razza, Ana G. Avila, Chris Baeken, Anna-Katharine Brem, Geraldo Busatto, Andre F. Carvalho, Adam Chekroud, Zafiris J. Daskalakis, Zhi-De Deng, Jonathan Downar, Wagner Gattaz, Colleen Loo, Paulo A. Lotufo, Maria da Graça M. Martin, Shawn M. McClintock, Jacinta O’Shea, Frank Padberg, Ives C. Passos, Giovanni A. Salum, Marie-Anne Vanderhasselt, Renerio Fraguas, Isabela Benseñor, Leandro Valiengo & Andre R. Brunoni. (2020) Precision non-implantable neuromodulation therapies: a perspective for the depressed brain. Brazilian Journal of Psychiatry 42:4, pages 403-419.
Crossref
Crossref
Felipe Cesar de Almeida Claudino, Leonardo Gonçalves, Felipe Barreto Schuch, Hugo Roberto Sampaio Martins & Neusa Sica da Rocha. (2020) The Effects of Individual Psychotherapy in BDNF Levels of Patients With Mental Disorders: A Systematic Review. Frontiers in Psychiatry 11.
Crossref
Crossref
Christoph Kraus, Bashkim Kadriu, Rupert Lanzenberger, Carlos A. ZarateJr.Jr. & Siegfried Kasper. (2020) Prognosis and Improved Outcomes in Major Depression: A Review. FOCUS 18:2, pages 220-235.
Crossref
Crossref
Peter Giacobbe, Karim Mithani, Venkat Bhat & Ying Meng. 2020. Major Depressive Disorder. Major Depressive Disorder
121
129
.
A. R. Brunoni, C. Szlejf, C. K. Suemoto, I. S. Santos, A. C. Goulart, M. C. Viana, A. Koyanagi, S. M. Barreto, A. B. Moreno, A. F. Carvalho, S. Lange, R. H. Griep, P. A. Lotufo & I.M. Benseñor. (2019) Association between ideal cardiovascular health and depression incidence: a longitudinal analysis of ELSA‐Brasil. Acta Psychiatrica Scandinavica 140:6, pages 552-562.
Crossref
Crossref
Christoph Kraus, Bashkim Kadriu, Rupert Lanzenberger, Carlos A. Zarate & Siegfried Kasper. (2019) Prognosis and improved outcomes in major depression: a review. Translational Psychiatry 9:1.
Crossref
Crossref
T. Vanicek, G. S. Kranz, B. Vyssoki, A. Komorowski, G. Fugger, A. Höflich, Z. Micskei, S. Milovic, R. Lanzenberger, A. Eckert, S. Kasper & R. Frey. (2019)
Repetitive enhancement of serum
BDNF
subsequent to continuation
ECT
. Acta Psychiatrica Scandinavica 140:5, pages 426-434.
Crossref
Crossref
Thomas Vanicek, Georg S. Kranz, Benjamin Vyssoki, Gernot Fugger, Arkadiusz Komorowski, Anna Höflich, Gertraud Saumer, Sergej Milovic, Rupert Lanzenberger, Anne Eckert, Siegfried Kasper & Richard Frey. (2019) Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression. Brain Stimulation 12:4, pages 1041-1050.
Crossref
Crossref
Laura Kranaster, Rainer Hellweg & Alexander Sartorius. (2019) Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels. Neuroscience Letters 704, pages 164-168.
Crossref
Crossref
Pia Baldinger-Melich, Gregor Gryglewski, Cécile Philippe, Gregory M. James, Chrysoula Vraka, Leo Silberbauer, Theresa Balber, Thomas Vanicek, Verena Pichler, Jakob Unterholzner, Georg S. Kranz, Andreas Hahn, Dietmar Winkler, Markus Mitterhauser, Wolfgang Wadsak, Marcus Hacker, Siegfried Kasper, Richard Frey & Rupert Lanzenberger. (2019) The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography. Brain Stimulation 12:3, pages 714-723.
Crossref
Crossref
Alexander Sartorius, Traute Demirakca, Andreas Böhringer, Christian Clemm von Hohenberg, Suna Su Aksay, Jan Malte Bumb, Laura Kranaster, Thomas Nickl-Jockschat, Michael Grözinger, Philipp A. Thomann, Robert Christian Wolf, Peter Zwanzger, Udo Dannlowski, Ronny Redlich, Maxim Zavorotnyy, Rebecca Zöllner, Isabel Methfessel, Matthias Besse, David Zilles & Gabriele Ende. (2019) Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients. Brain Stimulation 12:2, pages 335-343.
Crossref
Crossref
Andrea László, Lilla Lénárt, Lilla Illésy, Andrea Fekete & János Nemcsik. (2019) The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections. Journal of Neural Transmission 126:3, pages 265-278.
Crossref
Crossref
Matheus A. Pasquali, Bernard L. Harlow, Claudio N. Soares, Michael W. Otto, Lee S. Cohen, Luciano Minuzzi, Daniel P. Gelain, Jose Claudio F. Moreira & Benicio N. Frey. (2017) A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women. European Archives of Psychiatry and Clinical Neuroscience 268:8, pages 771-781.
Crossref
Crossref
Monica K. Chawla, Daniel T. Gray, Christie Nguyen, Harshaan Dhaliwal, Marc Zempare, Hiroyuki Okuno, Matthew J. Huentelman & Carol A. Barnes. (2018) Seizure-Induced Arc mRNA Expression Thresholds in Rat Hippocampus and Perirhinal Cortex. Frontiers in Systems Neuroscience 12.
Crossref
Crossref
Annamari Sorri, Kaija Järventausta, Olli Kampman, Kai Lehtimäki, Minna Björkqvist, Kati Tuohimaa, Mari Hämäläinen, Eeva Moilanen & Esa Leinonen. (2018) Effect of electroconvulsive therapy on brain‐derived neurotrophic factor levels in patients with major depressive disorder. Brain and Behavior 8:11.
Crossref
Crossref
K. Gbyl & P. Videbech. (2018) Electroconvulsive therapy increases brain volume in major depression: a systematic review and meta-analysis. Acta Psychiatrica Scandinavica 138:3, pages 180-195.
Crossref
Crossref
Karen M. Ryan, Ross Dunne & Declan M. McLoughlin. (2018) BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy. Brain Stimulation 11:5, pages 1123-1131.
Crossref
Crossref
Adiel C. Rios, Pawan Kumar Maurya, Mariana Pedrini, Maiara Zeni-Graiff, Elson Asevedo, Rodrigo B. Mansur, Andrea Wieck, Rodrigo Grassi-Oliveira, Roger S. McIntyre, Mirian A.F. Hayashi & Elisa Brietzke. (2017) Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders. Reviews in the Neurosciences 28:7, pages 739-749.
Crossref
Crossref
Amit Singh & Sujita Kumar Kar. (2017) How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms. Clinical Psychopharmacology and Neuroscience 15:3, pages 210-221.
Crossref
Crossref
Martin Bares, Tomas Novak, Martin Brunovsky, Miloslav Kopecek & Cyril Höschl. (2017) The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder. Journal of Nervous & Mental Disease 205:8, pages 618-626.
Crossref
Crossref
Suzanne D. Gonzalez, Aislinn J. Williams, Caren J. Blacker, Jennifer L. Vande Voort, Kathryn M. Schak, Charles B. Nemeroff, Alik S. Widge & Mauricio Tohen. (2017) Putative biological predictors of treatment response in bipolar disorders. Personalized Medicine in Psychiatry 1-2, pages 39-58.
Crossref
Crossref
Cristy Phillips. (2017) Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection. Neural Plasticity 2017, pages 1-17.
Crossref
Crossref
Cristy Phillips. (2017) Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder. Neural Plasticity 2017, pages 1-37.
Crossref
Crossref
Sudan Prasad Neupane. (2016) Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression. Frontiers in Immunology 7.
Crossref
Crossref
Renan Boeira Rocha, Eduardo Ronconi Dondossola, Antônio José Grande, Tamy Colonetti, Luciane Bisognin Ceretta, Ives C. Passos, Joao Quevedo & Maria Inês da Rosa. (2016) Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study. Journal of Psychiatric Research 83, pages 47-53.
Crossref
Crossref
Roumen V. Milev, Peter Giacobbe, Sidney H. Kennedy, Daniel M. Blumberger, Zafiris J. Daskalakis, Jonathan Downar, Mandana Modirrousta, Simon Patry, Fidel Vila-Rodriguez, Raymond W. Lam, Glenda M. MacQueen, Sagar V. Parikh & Arun V. Ravindran. (2016) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. The Canadian Journal of Psychiatry 61:9, pages 561-575.
Crossref
Crossref
Wolnei Caumo, Alícia Deitos, Sandra Carvalho, Jorge Leite, Fabiana Carvalho, Jairo Alberto Dussán-Sarria, Maria da Graça Lopes Tarragó, Andressa Souza, Iraci Lucena da Silva Torres & Felipe Fregni. (2016) Motor Cortex Excitability and BDNF Levels in Chronic Musculoskeletal Pain According to Structural Pathology. Frontiers in Human Neuroscience 10.
Crossref
Crossref
Thiago Fernando Vasconcelos Freire, Neusa Sica da Rocha & Marcelo Pio de Almeida Fleck. (2016) Combining ECT with pharmacological treatment of depressed inpatients in a naturalistic study is not associated with serum BDNF level increase. Journal of Psychiatric Research 76, pages 30-37.
Crossref
Crossref
Iraj Salehi, Seyed Mohammad Hosseini, Mohammad Haghighi, Leila Jahangard, Hafez Bajoghli, Markus Gerber, Uwe Pühse, Edith Holsboer-Trachsler & Serge Brand. (2016) Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder. Journal of Psychiatric Research 76, pages 1-8.
Crossref
Crossref
Thiago Fernando Vasconcelos Freire, Marcelo Pio de Almeida Fleck & Neusa Sica da Rocha. (2016) Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor ( BDNF). Brain Research Bulletin 121, pages 263-269.
Crossref
Crossref
A. Jorgensen, P. Magnusson, L. G. Hanson, T. Kirkegaard, H. Benveniste, H. Lee, C. Svarer, J. D. Mikkelsen, A. Fink-Jensen, G. M. Knudsen, O. B. Paulson, T. G. Bolwig & M. B. Jorgensen. (2016) Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression. Acta Psychiatrica Scandinavica 133:2, pages 154-164.
Crossref
Crossref
Ching-Hua Lin, Ming-Chao Chen, Wei-Cheng Yang & Hsien-Yuan Lane. (2016) Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy. European Neuropsychopharmacology 26:2, pages 225-233.
Crossref
Crossref
Nolan R Williams & Alan F Schatzberg. (2016) NMDA antagonist treatment of depression. Current Opinion in Neurobiology 36, pages 112-117.
Crossref
Crossref
André F. Carvalho, Cristiano A. Köhler, Roger S. McIntyre, Christian Knöchel, André R. Brunoni, Michael E. Thase, João Quevedo, Brisa S. Fernandes & Michael Berk. (2015) Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis. Psychoneuroendocrinology 62, pages 18-26.
Crossref
Crossref
M. Polyakova, M. L. Schroeter, B. M. Elzinga, S. Holiga, P. Schoenknecht, E. R. de Kloet & M. L. Molendijk. (2015) Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature. PLOS ONE 10:11, pages e0141564.
Crossref
Crossref
Miho Ota, Takamasa Noda, Noriko Sato, Mitsutoshi Okazaki, Masatoshi Ishikawa, Kotaro Hattori, Hiroaki Hori, Daimei Sasayama, Toshiya Teraishi, Daichi Sone & Hiroshi Kunugi. (2015) Effect of electroconvulsive therapy on gray matter volume in major depressive disorder. Journal of Affective Disorders 186, pages 186-191.
Crossref
Crossref
A.P. Allen, M. Naughton, J. Dowling, A. Walsh, F. Ismail, G. Shorten, L. Scott, D.M. McLoughlin, J.F. Cryan, T.G. Dinan & G. Clarke. (2015) Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT. Journal of Affective Disorders 186, pages 306-311.
Crossref
Crossref
Pingfu Feng, Afaf A. Akladious, Yufen Hu, Yousef Raslan, James Feng & Phillip J. Smith. (2015) 7,8-Dihydroxyflavone reduces sleep during dark phase and suppresses orexin A but not orexin B in mice. Journal of Psychiatric Research 69, pages 110-119.
Crossref
Crossref
Yupei P. Hu, Gopalkumar Rakesh & Sarah H. Lisanby. (2015) Recent Developments in Noninvasive Neuromodulation for Mood and Anxiety Disorders. Current Behavioral Neuroscience Reports 2:3, pages 173-185.
Crossref
Crossref
Sudan Prasad Neupane, Lars Lien, Thor Ueland, Tom Eirik Mollnes, Pål Aukrust & Jørgen G. Bramness. (2015) Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders. Alcohol 49:5, pages 471-478.
Crossref
Crossref
André Russowsky Brunoni, Bernardo Sampaio-Junior, Adriano Henrique Moffa, Lucas Borrione, Barbara Schwair Nogueira, Luana Vanessa Marotti Aparício, Beatriz Veronezi, Marina Moreno, Raquel Albano Fernandes, Diego Tavares, Priscila Vilela Silveira Bueno, Ole Seibt, Marom Bikson, Renerio Fraguas & Isabela Martins Benseñor. (2015) The Escitalopram versus Electric Current Therapy for Treating Depression Clinical Study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial. Sao Paulo Medical Journal 133:3, pages 252-263.
Crossref
Crossref
Chiara Rapinesi, Georgios D. Kotzalidis, Martina Curto, Daniele Serata, Vittoria R. Ferri, Paola Scatena, Paolo Carbonetti, Flavia Napoletano, Jessica Miele, Sergio Scaccianoce, Antonio Del Casale, Ferdinando Nicoletti, Gloria Angeletti & Paolo Girardi. (2015) Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels. Psychiatry Research 227:2-3, pages 171-178.
Crossref
Crossref
Alexandra Kleimann, Alexandra Kotsiari, Wolfgang Sperling, Michael Gröschl, Annemarie Heberlein, Kai G. Kahl, Thomas Hillemacher, Stefan Bleich, Johannes Kornhuber & Helge Frieling. (2014) BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy. Journal of Neural Transmission 122:6, pages 925-928.
Crossref
Crossref
Oga Sasaki, Mitsuhiro Kamata, Hisashi Higuchi, Mioto Maedomari, Toshiaki Haga, Takashi Nishio & Noboru Yamaguchi. (2015) Serum Brain-derived Neurotrophic Factor Levels Following Electroconvulsive Therapy in Treatment-resistant Depressed Patients. Journal of St. Marianna University 6:2, pages 253-261.
Crossref
Crossref
André R. Brunoni, Rodrigo Machado-Vieira, Carlos A. ZarateJr.Jr., Erica L.M. Vieira, Leandro Valiengo, Isabela M. Benseñor, Paulo A. Lotufo, Wagner F. Gattaz & Antonio L. Teixeira. (2015) Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 56, pages 91-96.
Crossref
Crossref
Mohammad Haghighi, Saeed Khodakarami, Leila Jahangard, Mohammad Ahmadpanah, Hafez Bajoghli, Edith Holsboer-Trachsler & Serge Brand. (2014) In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder. Journal of Psychiatric Research 58, pages 109-114.
Crossref
Crossref
Iraj Salehi, Seyed Mohammad Hosseini, Mohammad Haghighi, Leila Jahangard, Hafez Bajoghli, Markus Gerber, Uwe Pühse, Roumen Kirov, Edith Holsboer-Trachsler & Serge Brand. (2014) RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder. Journal of Psychiatric Research 57, pages 117-124.
Crossref
Crossref